ODDB.org: Open Drug Database

You are at -

003

Pemzek PLUS 16/12.5 mg, Tabletten - 28 Tablette(n)

Swissmedic Key	62499003 CM	Registration Holder	AstraZeneca AG
Name	Pemzek PLUS 16/12.5 mg, Tabletten	Date of registration	06.01.2012
Original/Generic	Original	Introduction of Sequence	06.01.2012
ATC-Classification	Candesartan and Diuretics (C09DA06)	Revision date
WHO	WHO-DDD	Valid until	05.01.2017
Index Therapeuticus (BSV)	02.07.20. Kombinierte blutdrucksenkende Mittel	Show package size	28 Tablette(n)
Index Therapeuticus (Swissmedic)	02.07.20. Kombinierte blutdrucksenkende Mittel	Description
Swissmedic categorie.	B
SL Eintrag	Yes	Indication
Information for professionals	IP	Consumer information	CI
Ex-factory-Price	11.88	Limitation	No
Date SL entry	01.05.2012
Deductible	10 % For this product you pay a 10 % deductible. Pay attention to your medical insurance bill!	Consumer price	25.95
Feedback	FB
EAN-Code	7680624990036	Medication Code	Synthetika human
Pharmacode	5258950

Composition

candesartanum cilexetilum 16 mg, hydrochlorothiazidum 12.5 mg, excipiens pro compresso.

Packungsbestandteile

28 Tablet(s)

Substance	Dose
Candesartanum Cilexetil	16 mg
Hydrochlorothiazide	12.5 mg
Galenic FormTablets

Source

Data was imported : 05.03.2012
Swissmedic Registration : 62499
Sequence : 02
Product name : Pemzek PLUS 16/12.5 mg, Tabletten
Registration owner: : AstraZeneca AG
Product group :
Index Therapeuticus (BSV) : 02.07.2.
Medication Code : Synthetika human
Date of registration : 06.01.2012
Valid until : 05.01.2017
Package number : 003
Show package size : 28
Commercial Form/Unit : Tablette(n)
Swissmedic categorie. : B
Active Agents : candesartanum cilexetilum, hydrochlorothiazidum
Composition : candesartanum cilexetilum 16 mg, hydrochlorothiazidum 12.5 mg, excipiens pro compresso.

2013